Flexion Therapeutics
FLXN
#7368
Rank
NZ$0.76 B
Marketcap
NZ$15.14
Share price
0.00%
Change (1 day)
7,567.24%
Change (1 year)

Market capitalization of Flexion Therapeutics (FLXN)

Last known market cap: NZ$0.76 Billion

As of February 2026 Flexion Therapeutics has a market cap of NZ$0.76 Billion. This makes Flexion Therapeutics the world's 7368th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Flexion Therapeutics from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$0.72 B7.58%
2021NZ$0.67 B-14.96%
2020NZ$0.79 B-32.99%
2019NZ$1.17 B84.12%
2018NZ$0.64 B-51.62%
2017NZ$1.32 B52.22%
2016NZ$0.86 B43.17%
2015NZ$0.60 B9.93%
2014NZ$0.55 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$909.08 B 119,201.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$249.60 B 32,656.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$0.20 B-73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$1.46 B 92.55%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$24.2 M-96.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
NZ$0.48 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$13.46 M-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA